Low‐Frequency Stimulation Provides Significant Added Benefit for Postpartum Urinary Incontinence: A Retrospective Cohort Study

Read full text Summarise with VIRAT
Authors: Yaxin Liang, Li Wei Gu, Tianzi Gai, Yaqing Yu, Xinyue Zhang, Min Li
Cited by: 0
References: 43

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

AIMS: To evaluate the clinical efficacy of low-frequency electrical stimulation (LES) in treating UI among postpartum women. METHODS: Postpartum women diagnosed with UI who received treatment at two tertiary hospitals between 1st January and 30th June 2020 were included. Patients received one of two regiments: (1) 10 sessions of functional electrical stimulation (FES) at 30-40 Hz combined with biofeedback (FES-BF group); (2) 4 sessions of LES (2-10 Hz) followed by 6 sessions of FES combined with biofeedback (LES-BF group). The primary outcome was the improvement in urine leakage frequency according to a 7-day bladder diary. The secondary outcomes included cure, severity of UI, quality of life, pelvic floor muscle strength, surface electromyography levels, pain intensity, and pelvic organ prolapse quantification. Multivariate logistic regression and double robust analysis were conducted. RESULTS: A total of 217 women were involved (LES-BF vs. FES-BF: 102 vs. 115). The LES-BF group demonstrated a significantly higher cure rate in urinary leakage frequency compared to the FES-BF group (36 [35.3%] vs. 25 [21.7%], χ² = 4.915, p = 0.027, OR = 2.85 [95% CI: 1.32 to 6.17]), which confirmed by doubly robust analysis (OR = 3.46, 95% CI: 1.66 to 7.19). We also found superior pelvic muscles strength recovery in the LES-BF group compared to FES-BF group (p < 0.05). CONCLUSIONS: The combination of LES and FES was associated with a significant short-term cure in postpartum UI over FES alone. This protocol could be a candidate treatment option for UI, justifying further validation in randomized controlled trials. CLINICAL TRIAL REGISTRATION: This study was registered at the Chinese Clinical Trial Registry (ChiCTR19000 21717).

Fields of Study & Subjects

Pelvic floor disorders treatments Urinary Bladder and Prostate Research Sexual function and dysfunction studies

Publication details

Journal / source
Neurourology and Urodynamics
Volume
45
Issue
6
Pages
1077–1085
Publication date
26 March 2026
Language
EN